Serologically assessed markers of fibroblast activity (PRO-C3 and PRO-C6) and risk assessment of pulmonary fibrosis following severe COVID-19 infection

Serologically assessed markers of fibroblast activity (PRO-C3 and PRO-C6) and risk assessment of pulmonary fibrosis following severe COVID-19 infection

Background Impaired lung function and fibrotic scarring of the lungs following severe COVID-19 infection are well-known manifestations. However, the risk factors and predisposing factors are still unknown. This study explored whether serological biomarkers for collagen synthesis associate with impai...

Full description

Saved in:
Bibliographic Details
Main Authors: Anne Orholm Nielsen, Kirsten Brændholt Rasmussen, Frederikke Bay Toft, Henning Bay Nielsen, Thomas Hildebrandt, Carsten Sloth, Alejandro E. Mayorca-Guiliani, Morten Karsdal, Diana Julie Leeming, Rikke Borg
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:European Clinical Respiratory Journal
Subjects:
COVID-19
pulmonary fibrosis
biomarkers
PRO-C3
PRO-C6
Online Access:https://www.tandfonline.com/doi/10.1080/20018525.2025.2510032
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/20018525.2025.2510032

Similar Items